共同药业 (300966.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(共同药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 233,822,011.21122,227,974.51566,399,208.58385,037,986.62267,821,256.77119,423,435.11604,571,473.19446,823,862.70268,347,371.40120,451,245.21
 营业利润(元) -10,159,007.582,235,254.4619,529,955.5315,085,471.0410,994,265.83-988,978.6938,903,531.1841,614,904.5428,990,345.7414,005,079.72
 利润总额(元) -11,343,177.511,935,693.2719,116,273.2618,560,673.6514,374,359.563,375,696.6438,513,699.0344,276,838.4829,271,626.6114,050,651.69
 净利润(元) -6,886,936.292,893,085.0721,289,866.9521,376,634.9516,632,100.653,651,134.2939,496,029.8239,380,724.7626,668,995.5212,776,354.19
 归属于母公司股东的净利润(元) -5,118,586.733,547,307.0423,005,014.7622,784,477.6517,472,034.334,024,418.0840,187,745.4339,917,456.0426,980,666.1813,044,337.80
盈利能力:
 销售毛利率(%) 17.3821.5722.0923.0322.3120.1322.8623.5925.6826.95
 销售净利率(%) -2.952.373.765.556.213.066.538.819.9410.61
 净资产收益率(%) -0.540.382.452.551.980.46----
 总资产报酬率ROA(%) -0.170.211.311.310.980.37----
 投入资本回报率ROIC(%) -0.250.181.241.271.010.232.903.262.211.22
营运能力:
 存货周转率(次) 0.460.231.070.680.470.22----
 应收账款周转率(次) 1.160.602.961.981.280.62----
 总资产周转率(次) 0.100.050.250.200.140.07----
偿债能力:
 资产负债率(%) 62.4658.5658.1754.6352.5652.5852.5648.0049.6635.57
 股东权益比率(%) 34.1638.6038.9243.0344.9544.8844.8748.8747.4261.63
 已获利息倍数(倍) -0.591.672.843.644.332.184.799.346.485.48
 流动比率 1.221.091.271.611.992.402.111.932.132.20
 速动比率 0.690.510.640.740.981.281.271.041.341.16
发展能力:
 营业收入增长率(%) -12.692.35-6.31-13.83-0.20-0.852.320.20-11.34-15.07
 营业利润增长率(%) -192.40326.02-49.80-63.75-62.08-107.06-37.96-21.05-29.00-20.65
 税后利润增长率(%) -129.30-11.86-42.78-42.92-35.24-69.15-48.69-26.17-34.26-14.62
 净资产增长率(%) 0.022.652.6614.6715.7013.6614.996.206.3149.29
 总资产增长率(%) 31.6219.3418.2930.2522.0556.0770.7661.1665.1760.96

前瞻产业研究院